// Deep Analysis

Research & Analysis.
In-Depth.

Full-length, AI-written pieces grounded in real filings and disclosures — factual filing digests and thesis-derived research analysis, distinct from the real-time wire feed.

12,836
Articles Published
Live
Feed Status
ALL ANALYSIS · 12,836 results Live
Filing Digest Sep 14

Inmune Bio Appoints Rare-Disease Execs to Board

Inmune Bio, Inc. (NASDAQ: INMB) announced on September 8, 2026, that its Board of Directors approved an increase in the number of directors, setting the total to seven. The company…